About this trial
The goal of this clinical trial is to investigate the added value of three-dimensional transvaginal ultrasound (3D TVUS) and gel infusion sonography (3D GIS) for diagnosing a partition in the uterus (uterine septum) in comparison to magnetic resonance imaging (MRI). The main question it aims to answer is:
How well do 3D TVUS and 3D GIS detect a uterine septum compared to MRI?
Participants will receive 3D TVUS/ 3D GIS and MRI, and will complete questionnaires.
Eligibility criteria
Qualifiers
Women aged between 18 and 45 years
With suspicion of a uterine septum on routine 2D TVUS
Who are willing to give informed consent
Disqualifiers
Women aged below 18 years and over 45 years
Prior definitive diagnosis of a uterine septum or other congenital uterine anomaly
Prior surgery in relation to a uterine septum
Cervical (unilateral) aplasia
Trial design
Treatments tested in this trial
- Magnetic Resonance Imaging
- Three-dimensional transvaginal ultrasound
- Three-dimensional transvaginal Gel Infusion Sonography
- Questionnaires
Treatment groups
Sponsors and collaborators
University Hospital, Ghent
Lead sponsor
Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)
Collaborator